FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Daniel Haley

Research Profile

Chemicals & Drugs

Procedures

Anatomy

Disorders

Physiology

Co-author Network

Publications

TOP 3
Edwin B Walker; Daniel Haley; Ulf Petrausch; Kevin Floyd; William Miller; Nelson Sanjuan; Greg Alvord; Fox Bernard; Walter J Urba
Phenotype and functional characterization of long-term gp100-specific memory CD8+ T cells in disease-free melanoma patients before and after boosting immunization.
Dominik Rüttinger; Rui Li; Christian H Poehlein; Daniel Haley; Edwin B Walker; Hong-Ming Hu; Fox Bernard
Increased susceptibility to immune destruction of B16BL6 tumor cells engineered to express a novel pro-Smac fusion protein.
Ulf Petrausch; Daniel Haley; William Miller; Kevin Floyd; Walter J Urba; Edwin Walker
Polychromatic flow cytometry: a rapid method for the reduction and analysis of complex multiparameter data.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Daniel Haley (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Edwin B Walker; Daniel Haley; Ulf Petrausch; Kevin Floyd; William Miller; Nelson Sanjuan; Greg Alvord; Fox Bernard; Walter J Urba
Phenotype and functional characterization of long-term gp100-specific memory CD8+ T cells in disease-free melanoma patients before and after boosting immunization.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(16):5270-83.
2008: Dominik Rüttinger; Rui Li; Christian H Poehlein; Daniel Haley; Edwin B Walker; Hong-Ming Hu; Fox Bernard
Increased susceptibility to immune destruction of B16BL6 tumor cells engineered to express a novel pro-Smac fusion protein.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(1):43-51.
2006: Ulf Petrausch; Daniel Haley; William Miller; Kevin Floyd; Walter J Urba; Edwin Walker
Polychromatic flow cytometry: a rapid method for the reduction and analysis of complex multiparameter data.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2006;69(12):1162-73.
2006: Hong He; Preya Wisner; Guojun Yang; Hong-Ming Hu; Daniel Haley; William Miller; Aisling O'Hara; W Gregory Alvord; Christopher H Clegg; Fox Bernard; Walter J Urba; Edwin B Walker
Combined IL-21 and low-dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor model.
Journal of translational medicine 2006;4():24.
2004: Edwin B Walker; Daniel Haley; William Miller; Kevin Floyd; Ketura P Wisner; Nelson Sanjuan; Holden T Maecker; Pedro Romero; Hong-Ming Hu; W Gregory Alvord; John W Smith; Fox Bernard; Walter J Urba
gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(2):668-80.
2004: Jun Ma; Christian H Poehlein; Shawn M Jensen; M G LaCelle; Tarsem Moudgil; Dominik Rüttinger; Daniel Haley; M J Goldstein; John W Smith; Brendan D Curti; H Ross; Edwin Walker; Hong-Ming Hu; Walter J Urba; Fox Bernard
Manipulating the host response to autologous tumour vaccines.
Developments in biologicals 2004;116():93-107; discussion 133-43.
2003: John W Smith; Edwin B Walker; Fox Bernard; Daniel Haley; Ketura P Wisner; Teri Doran; Brenda Fisher; Lisa Justice; William Wood; John T Vetto; Holden T Maecker; Annemieke Dols; Sybren L Meijer; Hong-Ming Hu; Pedro Romero; W Gregory Alvord; Walter J Urba
Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responses.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(8):1562-73.